<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01867905</url>
  </required_header>
  <id_info>
    <org_study_id>H12-01716</org_study_id>
    <secondary_id>H12-01716</secondary_id>
    <nct_id>NCT01867905</nct_id>
  </id_info>
  <brief_title>Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock</brief_title>
  <official_title>The Effect of Antibiotic Administration on Blood Culture Positivity in Patients With Severe Sepsis and Septic Shock: a Prospective Multicenter Observational Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>McGill University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sepsis is a significant cause health care expenditure and carries an extremely high rate of
      morbidity and mortality if not treated appropriately. From 1979 to 2000, sepsis resulted in
      over 10 million admissions to hospital in the United States with a mortality rate of 17.9 to
      27.8 percent. In Canada, it is estimated that the incidence of sepsis from 2008-2009 was
      103.3 per 100,000 per year.

      Advances in the multifaceted management of sepsis in recent years have resulted in improved
      clinical outcomes. However, the cornerstone of sepsis management relies on the prompt
      administration of appropriate antibiotics. Current clinical practice suggests that antibiotic
      administration can be delayed up to 45 minutes in order to obtain blood cultures, whose
      results have a profound impact on the type and duration of antimicrobial therapy.
      Unfortunately, this recommendation is based on very little evidence and the investigators
      have found that potential life-saving treatment is often delayed in order to abide by it.
      Furthermore, recent data suggest that mortality could be increased by approximately 5% by
      delaying antibiotic administration for that time period.

      The investigators therefore wish to organize a prospective, multi-centre trial in order to
      identify the effect of antibiotic administration on blood culture positivity in patients
      presenting with severe sepsis or septic shock. Other objectives will be to elucidate which
      patient factors, including age, co-morbid conditions and clinical presentation, as well as
      antibiotic choice will affect blood culture results.

      This study will be conducted in the emergency departments at St. Paul's Hospital (SPH),
      Vancouver General Hospital (VGH), Lion's Gate Hospital (LGH), Surrey Memorial Hospital,
      Montreal General Hospital and Royal Victoria Hospital. Patients identified for the
      aforementioned conditions will be treated as per routine hospital protocol. If the patient is
      deemed eligible for the study, a second set of blood of blood cultures will subsequently be
      drawn ideally between 30 and 60 minutes after the administration of antibiotic therapy.
      Subject demographic data will be collected pertaining to age, comorbid immunocompromised
      conditions, vital signs, laboratory tests pertaining to end organ dysfunction, suspected
      source of sepsis, the type antibiotics administered and the timing of antimicrobial
      administration with respect to the second set of blood cultures taken.

      Our hypothesis is that blood culture positivity in patients presenting with severe sepsis and
      septic shock will not be altered significantly by antibiotic therapy. If so, our study would
      strongly argue against delaying life-saving therapy and would thus greatly improve patient
      care in our local emergency rooms. If incorrect, our study would be the first to demonstrate
      the benefit of obtaining blood cultures before antibiotic therapy and would strengthen
      current recommendations.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2014</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The effect of antibiotic administration on blood culture positivity in patients with severe sepsis and septic shock: a prospective multicenter observational trial.</measure>
    <time_frame>Four months</time_frame>
    <description>The primary outcome is the measure of blood culture positivity before and after antibiotic administration.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">328</enrollment>
  <condition>Severe Sepsis</condition>
  <condition>Septic Shock</condition>
  <condition>Bacteremia</condition>
  <arm_group>
    <arm_group_label>Severe sepsis and septic shock</arm_group_label>
    <description>Patients who present in severe sepsis or septic shock will have blood cultures taken before and after antibiotic administration. The antibiotic choice will be determined by the emergency physician and the patients will be treated as per routine hospital protocol. No therapeutic interventions will be administered.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood cultures
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients (age &gt; 18) who present to the emergency department with severe sepsis/septic
        shock .
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients greater than 18 years of age who present to the emergency department with the
             diagnosis of severe sepsis/septic shock.

          -  This will include patients that have 2/4 systemic inflammatory response syndrome
             criteria, a suspected infection and either a initial serum lactate &gt;4mmol/L or a
             initial systolic blood pressure &lt; 90 millimeters of mercury.

        Exclusion Criteria:

          -  Patients in whom antibiotics have been administered &gt;2 hours prior to assessment.

          -  Patients with antibiotics in the community in the past 48 hours

          -  Patients with known severe coagulopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Sweet, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David Sweet, M.D.</last_name>
    <phone>604-875-4275</phone>
    <email>ddsweet@mail.ubc.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Matthew P Cheng, M.D.,C.M.</last_name>
    <phone>604-561-5301</phone>
    <email>matthew.cheng@mail.mcgill.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lions Gate Hospital</name>
      <address>
        <city>North Vancouver</city>
        <state>British Columbia</state>
        <zip>V7L 2L7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam C Davidson, M.D.</last_name>
      <email>adamcdavidson@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>David Sweet, M.D.</last_name>
      <phone>604-875-4275</phone>
      <email>ddsweet@mail.ubc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Adam C Davidson, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Sweet, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew P Cheng, M.D.,C.M.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew J Kadatz, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mypinder Sekhon, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick Doyle, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Surrey Memorial Hospital</name>
      <address>
        <city>Surrey</city>
        <state>British Columbia</state>
        <zip>V3V 1Z2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Stabler, PharmD</last_name>
      <email>sarah.stabler@fraserhealth.ca</email>
    </contact>
    <contact_backup>
      <last_name>David Sweet, MD</last_name>
      <email>ddsweet@mail.ubc.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Sweet, M.D.</last_name>
      <phone>604-875-4275</phone>
      <email>ddsweet@mail.ubc.ca</email>
    </contact>
    <contact_backup>
      <last_name>Matthew P Cheng, M.D.,C.M.</last_name>
      <phone>604-561-5301</phone>
      <email>matthew.cheng@mail.mcgill.ca</email>
    </contact_backup>
    <investigator>
      <last_name>David Sweet, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew P Cheng, M.D.,C.M.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew J Kadatz, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mypinder Sekhon, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick Doyle, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint-Paul's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6Z 1Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rob Stenstrom, M.D.</last_name>
      <email>robstenstrom@shaw.ca</email>
    </contact>
    <contact_backup>
      <last_name>David Sweet, M.D.</last_name>
      <phone>604-875-4275</phone>
      <email>ddsweet@mail.ubc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Rob Stenstrom, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Sweet, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew P Cheng, M.D.,C.M.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew J Kadatz, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mypinder Sekhon, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick Doyle, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montreal General Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3G 1A4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cedric P Yanousouni, MD</last_name>
      <phone>5149341934</phone>
      <phone_ext>53333</phone_ext>
      <email>cedric.yansouni@mcgill.ca</email>
    </contact>
    <contact_backup>
      <last_name>Matthew P Cheng, MDCM</last_name>
      <phone>5149341934</phone>
      <phone_ext>53333</phone_ext>
      <email>matthew.cheng@mail.mcgill.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Royal Victoria Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4A 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cedric P Yansouni, MD</last_name>
      <phone>5149341934</phone>
      <phone_ext>53333</phone_ext>
      <email>cedric.yansouni@mcgill.ca</email>
    </contact>
    <contact_backup>
      <last_name>Matthew P Cheng, MDCM</last_name>
      <phone>5149341934</phone>
      <phone_ext>53333</phone_ext>
      <email>matthew.cheng@mail.mcgill.ca</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2013</study_first_submitted>
  <study_first_submitted_qc>June 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2013</study_first_posted>
  <last_update_submitted>October 12, 2017</last_update_submitted>
  <last_update_submitted_qc>October 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Matthew Pellan Cheng</investigator_full_name>
    <investigator_title>Medical Resident</investigator_title>
  </responsible_party>
  <keyword>Severe sepsis</keyword>
  <keyword>Septic shock</keyword>
  <keyword>Bacteremia</keyword>
  <keyword>Antibiotics</keyword>
  <keyword>Blood culture positivity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Bacteremia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

